Clinical Trial Update: Tenapanor in Synucleinopathy-Related Constipation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tenapanor for constipation associated with synucleinopathies such as Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Synucleinopathy

Drugs mentioned

• Tenapanor (tenapanor)

Snippet

Sponsor: Cedar Valley Digestive Health Center | Conditions: Synucleinopathy, Parkinson's Disease | Phase 2 | Status: RECRUITING